These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6738181)

  • 1. [Results of the administration of sodium phosphate cellulose as medical treatment of primary hyperparathyroidism].
    Rapado A; Castrillo JM; Esbrit P; Barranco L; de la Piedra C; Traba ML
    Med Clin (Barc); 1984 Apr; 82(16):702-4. PubMed ID: 6738181
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium cellulose phosphate approved for absorptive hypercalciuria.
    FDA Drug Bull; 1983 Apr; 13(1):1-2. PubMed ID: 6852405
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypercalcemia with inorganic phosphate.
    Kistler HJ
    Helv Med Acta; 1967 Aug; 33(6):447-59. PubMed ID: 6081692
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of idiopathic hypercalciuria and nephrolithiasis with sodium cellulose phosphates.
    Teotia M; Teotia SP; Singh RK; Teotia NP
    J Assoc Physicians India; 1974 Oct; 22(10):709-14. PubMed ID: 4448804
    [No Abstract]   [Full Text] [Related]  

  • 5. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
    Pak CY
    Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with calcium-containing renal stones with cellulose phosphate.
    Pietrek J; Kokot F
    Br J Urol; 1973 Apr; 45(2):136-43. PubMed ID: 4706494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of urinary phosphorus elimination threshold: initial results].
    Thomas J; Monsaingeon A; Balan L; Thomas E; Levillain P; Steg A; Aboulker P
    Rein Foie; 1969-1970; 12():105-14. PubMed ID: 5405906
    [No Abstract]   [Full Text] [Related]  

  • 8. [The medical treatment of primary hyperparathyroidism].
    Lo Cascio V; Rossini M; Bertoldo F
    Recenti Prog Med; 1993 Apr; 84(4):287-95. PubMed ID: 8488334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the question of endocrine side effects in patients on medication for renal calcium stone disease (author's transl)].
    Ziegler R; Uhl K; Minne H; Russmann D; Döring B
    Urologe A; 1980 Jul; 19(4):226-30. PubMed ID: 7414768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phosphate treatment for hypercalcaemia].
    Alveryd A; Boström H; Edgren B; Widström A
    Nord Med; 1967 Oct; 78(43):1395-400. PubMed ID: 6058619
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary calcium and magnesium variations during sodium cellulose phosphate treatment.
    Trinchieri A; Mandressi A; Zanetti G; Patelli E; Donghi G; Rocco F
    Contrib Nephrol; 1984; 37():41-4. PubMed ID: 6713878
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Treatment of renal stones: cellulose phosphate or magnesium?
    Cook DA
    N Engl J Med; 1974 Nov; 291(19):1034-5. PubMed ID: 4414452
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():239-52. PubMed ID: 6938001
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypercalcemia in hyperparathyroidism. Response to prednisone.
    Gamble WS
    N Y State J Med; 1970 Feb; 70(3):427-9. PubMed ID: 5262244
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of radioimmunoassay of parathyroid hormone in diagnosis of hyperparathyroidism, renal calculi, hypercalcaemia and metabolic bone disease.
    Bergin A; Skrabanek P; Lanigan O; Duffy B; Powell D
    Ir Med J; 1981 Feb; 74(2):59-62. PubMed ID: 7228622
    [No Abstract]   [Full Text] [Related]  

  • 18. [The preliminary experiences of diagnosis and treatment for hypercalcemia crisis--clinical analysis of 23 cases].
    Xing X; Meng X; Zhan Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):116-21. PubMed ID: 7987937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of oral neutral-phosphate therapy.
    Bernstein DS; Pletka P
    Lancet; 1970 Nov; 2(7681):1031. PubMed ID: 4098062
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic hypercalcemia as a reversible cause of cognitive impairment: improvement after a single administration of pamidronate.
    Duque G; Segal R; Wise F; Bianco J
    J Am Geriatr Soc; 2005 Sep; 53(9):1633-4. PubMed ID: 16137304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.